Marcos Soto-Hernandez

Dr. Marcos Soto-Hernandez

Colegio de Postgraduados
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Plants
Verified
Journal Article
Open access
PDF file
MRMaría de la Luz Riviello-Flores
María de la Luz Riviello-Flores
JCJorge Cadena Cadena-Iñiguez
Jorge Cadena Cadena-Iñiguez
LRLucero M. Ruiz-Posadas
Lucero M. Ruiz-Posadas
MAMa. de Lourdes Arevalo-Galarza
Ma. de Lourdes Arevalo-Galarza
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
CCCarlos Roman Castillo-Martínez
Carlos Roman Castillo-Martínez
Agricultural biodiversity includes many species that have biological variants (natives, ecotypes, races, morphotypes). Their use is restricted to local areas because they do not fulfill the commercial requirements; however, it is well documented that these species are a source of metabolites, proteins, enzymes, and genes. Rescuing and harnessing them through traditional genetic breeding is time-consuming and expensive. Inducing mutagenesis may be a short-time option for its genetic improvement. A review of outstanding research was carried out, in order to become familiar with gene breeding using gamma radiation and its relevance to obtain outstanding agronomic characteristics for underutilized species. An approach was made to the global panorama of the application of gamma radiation in different conventional crop species and in vitro cultivated species, in order to obtain secondary metabolites, as well as molecular tools used for mutation screening. The varied effects of gamma radiation are essentially the result of the individual responses and phenotypic plasticity of each organism. However, even implicit chance can be reduced with specific genetic breeding, environmental adaptation, or conservation objectives.

23 March 2024 in Molecules
Verified
Journal Article
Open access
PDF file
JCJorge Cadena Cadena-Iñiguez
Jorge Cadena Cadena-Iñiguez
ESEdelmiro Santiago-Osorio
Edelmiro Santiago-Osorio
NFNancy Sánchez Flores
Nancy Sánchez Flores
LRLucero del Mar Ruiz-Posadas
Lucero del Mar Ruiz-Posadas
Marcos Soto-HernandezMarcos Soto-Hernandez
Marcos Soto-Hernandez
ISITZEN AGUIÑIGA SANCHEZ
ITZEN AGUIÑIGA SANCHEZ
Cancer is one of the leading causes of death worldwide, making the search for alternatives for its control a critical issue. In this context, exploring alternatives from natural sources, such as certain vegetables containing a variety of secondary metabolites with beneficial effects on the body and that play a crucial role in the fight against cancer, is essential. Among the compounds with the greatest efficacy in controlling this disease, those with antioxidant activity, particularly phenolic com-pounds, stand out. A remarkable example of this group is protocatechuic acid (PCA), which has been the subject of various revealing research on its activities in different areas. These studies sustain that protocatechuic acid has anti-inflammatory, antimutagenic, antidiabetic, antiulcer, antiviral, antifibrogenic, antiallergic, neuroprotective, antibacterial, anticancer, antiosteoporotic, anti-aging, and analgesic properties, in addition to offering protection against metabolic syndrome and con-tributing to the preservation of hepatic, renal, and reproductive functionality. Therefore, this paper aims to review the biological activities of PCA, focusing on its anticancer potential and its in-volvement in the control of various molecular pathways involved in tumor development, sup-porting its option as a promising alternative for cancer treatment.

1 January 2017 in Pharmaceutical Biology
Verified
Journal Article
Open access
ISITZEN AGUIÑIGA SANCHEZ
ITZEN AGUIÑIGA SANCHEZ
JCJorge Cadena-Íñiguez
Jorge Cadena-Íñiguez
ESEdelmiro Santiago-Osorio
Edelmiro Santiago-Osorio
GGGuadalupe Gómez-García
Guadalupe Gómez-García
VMVíctor Manuel Mendoza-Núñez
Víctor Manuel Mendoza-Núñez
Marcos Soto-HernandezMarcos Soto-Hernandez
Marcos Soto-Hernandez
Context: Sechium edule (Jacq.) Sw. (Cucurbitaceae) is used in ethnomedicine, but the diversity of the varietal groups of this species has not often been considered. This is important because we previously reported that different variety of species exhibit different activities across different tumor cell lines. Objective: This study investigates the chemical composition and biological activities of extracts obtained from S. edule var. nigrum spinosum. Materials and methods: The leukemia P388 cell line and mononuclear bone marrow cells (MNCBMs) were treated with the extract at a concentration ranging from 40 to 2370 μg/mL for cytotoxicity and viability assays. CD-1 mice were treated with 8–5000 mg/kg extract and monitored every hour for the first 24 h and subsequently for seven days for signs of toxicity (LD50). In addition, the chromatographic profile of the extract was determined by HPLC. Results: The extract inhibits the proliferation of both P388 cells and MNCBMs, with IC50 values of 927 and 1911 μg/mL, respectively, but reduced the viability and induced the apoptosis of only leukemia cells. The LD50 was higher than 5000 mg/kg, and this concentration did not alter the blood chemistry or cell count but doubled the mitotic index in the bone marrow. The HPLC showed the presence of cucurbitacins, phloridzin, naringenin, phloretin, apigenin, and gallic, chlorogenic, vanillic, p-hydroxybenzoic, caffeic, and p-coumaric acids. Discussion and conclusion: Sechium edule var. nigrum spinosum contains bioactive compounds that explain the antiproliferative and nutraceutical activities, and its lack of physiological side effects constitutes an added value to a widely consumed vegetable.

20 September 2024 in Plants
Verified
Journal Article
Open access
PDF file
Luis Manuel Carrillo-LópezLuis Manuel Carrillo-López
Luis Manuel Carrillo-López
CVClemente Villanueva-Verduzco
Clemente Villanueva-Verduzco
EVEvert Villanueva-Sánchez
Evert Villanueva-Sánchez
MFMarja L. Fajardo-Franco
Marja L. Fajardo-Franco
MAMartín Aguilar-Tlatelpa
Martín Aguilar-Tlatelpa
Marcos Soto-HernandezMarcos Soto-Hernandez
Marcos Soto-Hernandez
Currently, the excessive use of pesticides has generated environmental pollution and harmful effects on human health. The controlled release of active ingredients through the use of nanomaterials (NMs) appears to reduce human exposure and ecosystem alteration. Although the use of NMs can offer an alternative to traditional methods of disease diagnosis and control, it is necessary to review the current approach to the application of these NMs. This review describes the most recent and significant advances in using NMs for diagnosing and treating plant diseases (bacteria, phytopathogenic fungi, viruses, and phytopathogenic nematodes) in cultivated plants. Most studies have focused on reducing, delaying, or eliminating bacteria, fungi, viruses, and nematodes in plants. Both metallic (including metal oxides) and organic nanoparticles (NPs) and composites are widely used in diagnosing and controlling plant diseases due to their biocompatibility and ease of synthesis. Few studies have been carried out with regard to carbon-based NPs due to their toxicity, so future studies should address the development of detection tools, ecological and economic impacts, and human health. The synergistic effect of NMs as fertilizers and pesticides opens new areas of knowledge on the mechanisms of action (plant–pathogen–NMs interaction), the interaction of NMs with nutrients, the effects on plant metabolism, and the traceability of NMs to implement sustainable approaches. More studies are needed involving in vivo models under international regulations to ensure their safety. There is still controversy in the release of NMs into the environment because they could threaten the stability and functioning of biological systems, so research in this area needs to be improved.

16 December 2019 in Journal of Food Science and Technology
Verified
Journal Article
Closed access
PDF file
CHClaudia Hernandez-Aguilar
Claudia Hernandez-Aguilar
ADArturo Dominguez-Pacheco
Arturo Dominguez-Pacheco
MPMariana Palma-Tenango
Mariana Palma-Tenango
CVCarmen Valderrama-Bravo
Carmen Valderrama-Bravo
Marcos Soto-HernandezMarcos Soto-Hernandez
Marcos Soto-Hernandez
Jose  Ordonez-MirandaJose Ordonez-Miranda
Jose Ordonez-Miranda

26 October 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ETEUGENIA ELISA DELGADO TIBURCIO
EUGENIA ELISA DELGADO TIBURCIO
JCJorge Cadena Cadena-Iñiguez
Jorge Cadena Cadena-Iñiguez
ESEdelmiro Santiago-Osorio
Edelmiro Santiago-Osorio
LRLucero M. Ruiz-Posadas
Lucero M. Ruiz-Posadas
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
Marcos Soto-HernandezMarcos Soto-Hernandez
Marcos Soto-Hernandez
Cucurbitacins are a class of secondary metabolites initially isolated from the Cucurbitaceae family. They are important for their analgesic, anti-inflammatory, antimicrobial, antiviral, and anticancer biological actions. This review addresses pharmacokinetic parameters recently reported, including absorption, metabolism, distribution, and elimination phases of cucurbitacins. It includes recent studies of the molecular mechanisms of the biological activity of the most studied cucurbitacins and some derivatives, especially their anticancer capacity, to propose the integration of the pharmacokinetic profiles of cucurbitacins and the possibilities of their use. The main botanical genera and species of American origin that have been studied, and others whose chemo taxonomy makes them essential sources for the extraction of these metabolites, are summarized.